FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileOncoSil Medical Ltd
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
OSL.AX
OncoSil Medical Ltd Stock AnalysisComprehensive stock analysis for OncoSil Medical Ltd (OSL.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisOSL.AX
OSL.AX
OncoSil Medical Ltd
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
OSL.AX
  1. Home
  2. Stocks
  3. OncoSil Medical Ltd

OncoSil Medical Ltd

🇦🇺OSL.AX•ASX

OncoSil Medical Ltd

🇦🇺OSL.AX•ASX

Your view on OSL.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About OncoSil Medical Ltd

Industry
Medical - Devices
Sector
Healthcare
CEO
Nigel Lange
Headquarters
7 Eden Park Drive, Macquarie Park, NSW, AU
Industry
Medical - Devices
Sector
Healthcare
CEO
Nigel Lange
Headquarters
7 Eden Park Drive, Macquarie Park, NSW, AU
Description

OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma.

The company’s lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for OncoSil Medical Ltd. Starting points for OncoSil Medical Ltd: EPS -AUD 0.40, beta 1.17 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for OncoSil Medical Ltd. OncoSil Medical Ltd does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for OncoSil Medical Ltd. Trailing twelve-month EPS for OncoSil Medical Ltd stands at -AUD 0.40. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for OncoSil Medical Ltd. OncoSil Medical Ltd has reported as a listed company since 2005. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold OSL.AX12 companies
More Medical - Devices companies
TickerTypeCompanySectorExchangeMkt cap
ADMTADM Tronics Unlimited, Inc.HealthcareOTC$6.8M
ADR.AXAdherium LimitedHealthcareASX—
AEMDAethlon Medical, Inc.HealthcareNASDAQ$2.7M
AFIBAcutus Medical, Inc.HealthcareOTC$5,982
AHCOAdaptHealth Corp.HealthcareNASDAQ$1.0B
ALGNAlign Technology, Inc.HealthcareNASDAQ$11.6B
ALRTFALR Technologies Inc.HealthcareOTC$8.2M
ALURAllurion Technologies Inc.HealthcareOTC$11.0M
AMBBYAmbu A/SHealthcareOTC$3.3B
AMBFFAmbu A/SHealthcareOTC$3.7B
AMIXAutonomix Medical, Inc. Common StockHealthcareNASDAQ$592,199
AORTArtivion, Inc.HealthcareNYSE$904.6M
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for OncoSil Medical Ltd. Coverage tracks OncoSil Medical Ltd within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of OncoSil Medical Ltd.

OSL.AX AnalysisFair
Past
1
Growth
5
Health
5
Profit
1
Value
1

News

Latest Market News